CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, announced today that its proprietary gamma sensory stimulation at 40Hz over a 6-month period reduced white matter atrophy in the brain for ...
A study questioned the use of brain volume loss as a clinical trial endpoint in PPMS after finding a weak link to disability progression.
The Healthy @Reader's Digest on MSN
80-Year-Olds with Brains Like They’re 50 Have This One Thing in Common, Just Found a 25-Year Study
An international team says this is the first study to uncover this "resilience signature." ...
The new generation of Alzheimer's disease drugs—the first proven to change the course of the disease—typically extend ...
Subtle drops in activity levels detected by wrist-worn sensors may predict worsening disability in MS patients, per a study.
The last patient in Lundbeck’s phase 3 clinical trial, MASCOT, has been randomised ahead of schedule in a study evaluating amlenetug as a potential treatment for multiple system atrophy (MSA). The ...
According to the Alzheimer’s Association, more than 7 million Americans are living with Alzheimer’s, a disease that is a form ...
Musician Billy Joel recently canceled his concert tour, announcing he will undergo physical therapy for a condition called normal pressure hydrocephalus that is affecting his hearing, vision and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results